Urania Therapeutics Competitors and Similar CompaniesClear all

Urania Therapeutics's competitors and similar companies include Teknova, Mycenax Biotech and t2cure.

	Urania Therapeutics Urania Therapeutics (formerly RiboStruct) is a company developing treatments for genetic diseases caused by mutations.	Teknova Alpha Teknova is a biotech company developing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics.	Mycenax Biotech Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services.	t2cure t2cure is a biopharmaceutical company that develops progenitor cell-based regenerative therapeutics.
Founding Date	Founding Date 2015	Founding Date 1996	Founding Date 2001	Founding Date 2006
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics life sciences pharma	Tags Healthcare biotech drug development genetics life sciences medical diagnostics pharma	Tags Healthcare biotech drug development genetics life sciences pharma	Tags Healthcare biotech drug development genetics life sciences pharma
Locations	Locations Illkirch-Graffenstaden, FR HQ	Locations Hollister, US HQ	Locations Zhunan, TW HQ Taipei, TW Zhunan, TW	Locations Frankfurt am Main, DE HQ
Employees	Employees 2	Employees 21026% decrease	Employees 387	Employees N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2025)	Revenue (est.) NT$740.2m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $27.1m (FY, 2025)	Cost of goods NT$637.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $13.4m (FY, 2025)	Gross profit NT$114.2m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($17.3m) (FY, 2025)	Net income (NT$448.6m) (FY, 2025)	Net income N/A